MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension

Summary

The study had a 4 week single blind placebo period followed by 12 weeks of double blind treatment. Patients were randomized to one of four treatment arms to evaluate the antihypertensive efficacy of Losartan.

Timeline

Start

1992-05

Primary completion

1993-01

Completion

1993-02

Drugs

Indications